Explanation at the opioid receptor level for differing toxicity of morphine and morphine 6-glucuronide.

por Hucks, D., Thompson, P. I., McLoughlin, L., Joel, S. P., Patel, N., Grossman, A., Rees, L. H., Slevin, M. L.
Publicado 1992

A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas.

por Johnson, P. W., Thompson, P. I., Seymour, M. T., Deasy, N. P., Thuraisingham, R. C., Slevin, M. L., Wrigley, P. F.
Publicado 1991

Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent

por Jameson, M B, Thompson, P I, Baguley, B C, Evans, B D, Harvey, V J, Porter, D J, McCrystal, M R, Small, M, Bellenger, K, Gumbrell, L, Halbert, G W, Kestell, P
Publicado 2003